MLF1
MLF1 (myeloid leukaemia factor 1) is an oncoprotein involved in the lineage commitment of haematopoietic progenitors, favouring myeloid over erythroid formation. It belongs to the myeloid leukaemia factor family and has been linked to myelodysplastic syndrome and acute myeloid leukaemia. Browse Assay Genie's current range of MLF1 research reagents below, or read on for the biology behind the target.
MLF1 is involved in the lineage commitment of primary haemopoietic progenitors, where it restricts erythroid formation and enhances myeloid formation. It interferes with erythropoietin-induced erythroid terminal differentiation by preventing cells from exiting the cell cycle, an effect mediated through suppression of CDKN1B/p27Kip1 levels. MLF1 also suppresses COP1 activity via CSN3, which activates p53 and induces cell cycle arrest.
The protein binds DNA and affects the expression of a number of genes, so it may function as a transcription factor in the nucleus. UniProt records MLF1 in the cytoplasm and nucleus, and also in the cilium, including the cilium basal body of the cytoskeleton. The human protein is a member of the MLF family, and the mouse ortholog is Mlf1. The MLF1 gene is the subject of research into how haematopoietic cell fate is determined.
NCBI Gene describes MLF1 as an oncoprotein thought to play a role in the phenotypic determination of haemopoietic cells. Translocations between this gene and nucleophosmin have been associated with myelodysplastic syndrome and acute myeloid leukaemia. Multiple transcript variants encoding different isoforms have been found, which is relevant when designing experiments to detect the MLF1 protein.
MLF1 restricts erythroid formation and enhances myeloid formation in progenitors, making it a subject of study in lineage commitment.
Translocations joining MLF1 and nucleophosmin are associated with myelodysplastic syndrome and acute myeloid leukaemia.
MLF1 suppresses CDKN1B/p27Kip1 levels and, through COP1 and CSN3, activates p53 and induces cell cycle arrest.
MLF1 binds DNA and affects the expression of a number of genes, suggesting a possible nuclear transcription factor role.
MLF1 helps determine haemopoietic progenitor fate by restricting erythroid formation and enhancing myeloid formation. It prevents erythropoietin-driven cells from exiting the cell cycle by lowering CDKN1B/p27Kip1, and it suppresses COP1 activity via CSN3, activating p53. It also binds DNA and may act as a nuclear transcription factor.
The approved HGNC name is myeloid leukaemia factor 1, and the symbol is MLF1; no alternative aliases or previous symbols are listed. NCBI Gene reports multiple transcript variants encoding different isoforms, so check the datasheet of any product for its validated reactivity and isoform coverage.
NCBI Gene describes MLF1 as an oncoprotein, and translocations between MLF1 and nucleophosmin are associated with myelodysplastic syndrome and acute myeloid leukaemia. A mouse ortholog, Mlf1, exists. Check the datasheet of any product for its validated reactivity.
Cell cycle regulators, haematopoietic factors and leukaemia-associated partners connected to MLF1 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P58340; product specifications from Assay Genie datasheets.